It is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The company said introducing the Drug Controller General of India (DCGI)approved new drug delivery system will make it more affordable and accessible in India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cOfMusY
via IFTTT
No comments:
Post a Comment